Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the copy of newspaper advertisement of Notice of the Meeting of the Board of Directors of Themis Medicare Limited scheduled to be held on Wednesday, August 7, 2019, published in The Times of India - (English Newspaper) and The Economic Times - Ahmedabad Gujarat (Gujarati Newspaper) on July 30, 2019 for your reference.
30-07-2019
Bigul

THEMIS MEDICARE LTD. - 530199 - Update On Litigation

 This is further to our initial disclosure on the captioned matter made on July 12, 2018 followed by an update on the same dated 8th July, 2019. This is to apprise you that in relation to a litigation related to a key product of the Company wherein the Hon'ble Delhi High Court vide its order dated July 5, 2018 had dismissed the Company's petition and on which the Company had preferred an appeal at the division bench of the Hon''ble Delhi High court against the final order of the single judge. The Company's appeal has been admitted in the court. Hence, the matter is now subjudice. This may be taken as a disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015. The Company will keep the Stock Exchange informed of any further developments in this matter.
27-07-2019
Bigul

Themis Medicare Ltd - 530199 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Un - Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2019.

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2019 ,inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2019.
25-07-2019
Bigul

THEMIS MEDICARE LTD. - 530199 - Clarification

 With reference to increase in Price, Themis Medicare Ltd has submitted to BSE a copy of Clarification is enclosed.
18-07-2019
Bigul

Themis Medicare Ltd - 530199 - Clarification sought from Themis Medicare Ltd

 The Exchange has sought clarification from Themis Medicare Ltd on July 18, 2019, with reference to increase in Price.The reply is awaited.
18-07-2019
Bigul

Themis Medicare Ltd - 530199 - Shareholding for the Period Ended June 30, 2019

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
17-07-2019
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2019 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
15-07-2019
Bigul

Themis Medicare Ltd - 530199 - Statement Of Investor Complaints For The Quarter Ended June 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Mr. Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
15-07-2019
Bigul

Themis Medicare Ltd - 530199 - Update On Litigation

 We, hereby, inform you that the Company had received a letter dated 11th July, 2018 from the Food and Drug Administration (FDA) authorities directing, inter alia, not to manufacture a key product till deciding of the matter. The Company, being aggrieved by the developments, had filed a Writ Petition in the Hon''ble Delhi High Court in this connection and the same was admitted by the Hon''ble Delhi High Court. However, the Hon'ble Delhi High Court vide its order dated July 5, 2018 has dismissed the Company's petition. Meanwhile, since the Court has uploaded a copy of the same on its website, the Company is hereby making the disclosure. Also the Company has applied for a certified copy of the order and the same is awaited. The Company believes it has a strong case and intends to file an appeal against the said order in consultation with its lawyers. This may be taken as a disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015.
08-07-2019
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2nd April, 2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1st July, 2019 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30th June, 2019 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter ended 30th June, 2019 shall be intimated in due course. We request you to kindly take the above information on record.
28-06-2019
Next Page
Close

Let's Open Free Demat Account